Daniel Malouli
5Patents
3h-index
6Co-inventors
42Inventor score
Filing activity: Mar 5, 2014 → Jan 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9783823B2 | Cytomegalovirus vectors enabling control of T cell targeting | Chemistry; Metallurgy | 13 | Active |
| US10316334B2 | Cytomegalovirus vectors enabling control of T cell targeting | Chemistry; Metallurgy | 4 | Active |
| US10532099B2 | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules | Emerging Cross-Sectional Technologies | 4 | Active |
| US11091779B2 | Methods and compositions useful in generating non canonical CD8+ T cell responses | Emerging Cross-Sectional Technologies | 0 | Active |
| US11305015B2 | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.